Do anxiety and depression have a common pathophysiological mechanism?

Area of Science:

• Neuroendocrinology
• Psychiatry
• Neuroscience

Background:

• Anxiety and depression share overlapping symptoms and neurobiological underpinnings.
• Dysregulation of neurotransmitter systems, particularly noradrenergic and serotonergic pathways, is implicated in both disorders.
• The hypothalamic-pituitary-adrenal (HPA) axis plays a crucial role in the stress response and is frequently disrupted in mood disorders.

Purpose of the Study:

• To review and examine existing literature on anxiety and depression.
• To propose a unified mechanism for anxiety and depression.
• To investigate the roles of neurotransmitter systems and HPA axis dysregulation.

Main Methods:

• Literature search of Medline, Excerpta Medica, and PsychLIT databases.
• Review and classification of human and animal studies on monoamine receptors and HPA axis pathophysiology.
• Examination of a proposed neuroendocrine continuum model for anxiety and depression.

Main Results:

• Increased corticotropin-releasing factor (CRF) in cerebrospinal fluid is observed in both anxiety and depression.
• Anxiety is associated with hypocortisolemia and increased glucocorticoid receptors.
• Depression is characterized by hypercortisolemia and decreased glucocorticoid receptors, potentially due to hippocampal damage and CRF receptor desensitization.

Conclusions:

• A neuroendocrine continuum model is proposed to explain the distinct HPA axis regulation in anxiety and depression.
• Further research is needed to test this hypothesis by examining receptor changes and endocrine factor dysregulation mechanisms.